L2L L2L Microarray Analysis Tool

Results for S01CB.profile.u50

Results summary View all lists in GO:BiolProc View all genes in S01CB.profile.u50
List Name Description Total
probes
Expected
matches
Actual
matches
Fold
Enrichment
Binomial
p-value
negative regulation of transcription Any process that stops, prevents or reduces the frequency, rate or extent of transcription. 439 1.09 8 7.37 1.74e-05
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process Any process that stops, prevents or reduces the frequency, rate or extent of the chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids. 478 1.18 8 6.77 3.18e-05
transcription from RNA polymerase II promoter The synthesis of RNA from a DNA template by RNA polymerase II (Pol II), originating at a Pol II-specific promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). 997 2.46 11 4.46 5.26e-05
negative regulation of cellular metabolic process Any process that stops, prevents or reduces the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances. 536 1.32 8 6.04 7.06e-05
negative regulation of transcription from RNA polymerase II promoter Any process that stops, prevents or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. 201 0.50 5 10.06 1.61e-04
negative regulation of metabolic process Any process that stops, prevents or reduces the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism. 615 1.52 8 5.26 1.80e-04
regulation of Rho GTPase activity Any process that modulates the activity of a GTPase of the Rho family. 9 0.02 2 89.90 2.17e-04
negative regulation of small GTPase mediated signal transduction Any process that stops, prevents or reduces the frequency, rate or extent of small GTPase mediated signal transduction. 9 0.02 2 89.90 2.17e-04
positive regulation of B cell proliferation Any process that activates or increases the rate or extent of B cell proliferation. 10 0.02 2 80.91 2.71e-04
negative regulation of cell-cell adhesion Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell. 11 0.03 2 73.55 3.31e-04
negative regulation of B cell activation Any process that stops, prevents or reduces the frequency, rate or extent of B cell activation. 11 0.03 2 73.55 3.31e-04
erythrocyte differentiation The process by which a myeloid precursor cell acquires specializes features of an erythrocyte. 54 0.13 3 22.47 3.41e-04
regulation of cell-matrix adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to the extracellular matrix. 12 0.03 2 67.42 3.97e-04
regulation of transcription from RNA polymerase II promoter Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. 701 1.73 8 4.62 4.28e-04
regulation of cell-cell adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to another cell. 13 0.03 2 62.24 4.68e-04
regulation of T-helper cell differentiation Any process that modulates the frequency, rate or extent of T-helper cell differentiation. 13 0.03 2 62.24 4.68e-04
cytokine production during immune response The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus during an immune response, resulting in an increase in its intracellular or extracellular levels. 14 0.03 2 57.79 5.45e-04
regulation of production of molecular mediator of immune response Any process that modulates the frequency, rate, or extent of the production of molecular mediator of immune response. 14 0.03 2 57.79 5.45e-04
regulation of cytokine production during immune response Any process that modulates the frequency, rate, or extent of cytokine production during immune response. 14 0.03 2 57.79 5.45e-04
regulation of B cell proliferation Any process that modulates the frequency, rate or extent of B cell proliferation. 16 0.04 2 50.57 7.17e-04
cell activation during immune response A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response. 17 0.04 2 47.59 8.11e-04
lymphocyte activation during immune response A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. 17 0.04 2 47.59 8.11e-04
T cell activation during immune response The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response. 17 0.04 2 47.59 8.11e-04
T cell differentiation during immune response The process whereby an antigenically nave T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells. 17 0.04 2 47.59 8.11e-04
alpha-beta T cell differentiation during immune response The process whereby an antigenically nave alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells. 17 0.04 2 47.59 8.11e-04
CD4-positive, alpha-beta T cell differentiation during immune response The process whereby an antigenically nave CD4-positive, alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells. 17 0.04 2 47.59 8.11e-04
leukocyte activation during immune response A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. 17 0.04 2 47.59 8.11e-04
T-helper cell differentiation The process whereby a relatively unspecialized thymocyte acquires specialized features of a T-helper cell. 17 0.04 2 47.59 8.11e-04
negative regulation of transcription, DNA-dependent Any process that stops, prevents or reduces the frequency, rate or extent of DNA-dependent transcription. 292 0.72 5 6.93 8.77e-04
regulation of isotype switching Any process that modulates the frequency, rate or extent of isotype switching. 18 0.04 2 44.95 9.11e-04
CD4-positive, alpha beta T cell differentiation The process whereby a relatively unspecialized T cell acquires specialized features of a mature CD4-positive, alpha-beta T cell. 19 0.05 2 42.58 1.02e-03
negative regulation of cellular process Any process that stops, prevents or reduces the frequency, rate or extent of cellular processes, those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level. 1642 4.06 12 2.96 1.02e-03
negative regulation of immune system process Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process. 20 0.05 2 40.45 1.13e-03
regulation of immune effector process Any process that modulates the frequency, rate, or extent of an immune effector process. 20 0.05 2 40.45 1.13e-03
T-helper 2 type immune response An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is typically orchestrated by the production of particular cytokines by T-helper 2 cells, most notably IL-4, IL-5, IL-10, and IL-13, resulting in enhanced production of certain antibody isotypes and other effects. 20 0.05 2 40.45 1.13e-03
negative regulation of immune response Any process that stops, prevents or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. 20 0.05 2 40.45 1.13e-03
negative regulation of biological process Any process that stops, prevents or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. 1697 4.19 12 2.86 1.34e-03
regulation of adaptive immune response Any process that modulates the frequency, rate, or extent of an adaptive immune response. 23 0.06 2 35.18 1.49e-03
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. Any process that modulates the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. 23 0.06 2 35.18 1.49e-03
regulation of T cell differentiation Any process that modulates the frequency, rate or extent of T cell differentiation. 23 0.06 2 35.18 1.49e-03
negative regulation of cell differentiation Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation. 90 0.22 3 13.48 1.51e-03
regulation of defense response Any process that modulates the frequency, rate or extent of a defense response. 25 0.06 2 32.36 1.77e-03
positive regulation of locomotion Any process that activates or increases the frequency, rate or extent of locomotion of a cell or organism. 25 0.06 2 32.36 1.77e-03
regulation of inflammatory response Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. 25 0.06 2 32.36 1.77e-03
positive regulation of B cell activation Any process that activates or increases the frequency, rate or extent of B cell activation. 25 0.06 2 32.36 1.77e-03
positive regulation of cell motility Any process that activates or increases the frequency, rate or extent of the movement of a cell. 25 0.06 2 32.36 1.77e-03
negative regulation of apoptosis Any process that stops, prevents or reduces the frequency, rate or extent of cell death by apoptosis. 345 0.85 5 5.86 1.82e-03
negative regulation of programmed cell death Any process that stops, prevents or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. 347 0.86 5 5.83 1.87e-03
B cell proliferation The rapid expansion of a B cell population by cell division. Follows B cell activation. 27 0.07 2 29.97 2.06e-03
alpha-beta T cell differentiation The process whereby a relatively unspecialized hemopoietic stem cell acquires the specialized features of an alpha-beta T cell. 28 0.07 2 28.90 2.21e-03
somatic recombination of immunoglobulin genes during immune response The process by which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of an immune response. 30 0.07 2 26.97 2.54e-03
somatic diversification of immunoglobulins during immune response The somatic process by means of which sequence diversity of immunoglobulins is generated after the induction of an immune response. 30 0.07 2 26.97 2.54e-03
immunoglobulin production during immune response The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus during an immune response, resulting in an increase in its intracellular or extracellular levels. 30 0.07 2 26.97 2.54e-03
isotype switching The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus. 30 0.07 2 26.97 2.54e-03
regulation of lymphocyte differentiation Any process that modulates the frequency, rate or extent of lymphocyte differentiation. 30 0.07 2 26.97 2.54e-03
negative regulation of developmental process Any process that stops, prevents or reduces the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). 110 0.27 3 11.03 2.68e-03
somatic diversification of immune receptors via germline recombination within a single locus The process by which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus. 31 0.08 2 26.10 2.71e-03
somatic cell DNA recombination Recombination occurring within or between DNA molecules in somatic cells. 31 0.08 2 26.10 2.71e-03
somatic recombination of immunoglobulin gene segments The process by which immunoglobulin genes are formed through recombination of the germline genetic elements, as known as immunoglobulin gene segments, within a single locus. 31 0.08 2 26.10 2.71e-03
regulation of response to stimulus Any process that modulates the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. 32 0.08 2 25.28 2.88e-03
somatic diversification of immune receptors The somatic process allowing for the production of immune receptors whose specificity is not encoded in the germline genomic sequences. 34 0.08 2 23.80 3.25e-03
circadian rhythm The biological processes in an organism that recur with a regularity of approximately 24 hours. 34 0.08 2 23.80 3.25e-03
somatic diversification of immunoglobulins The somatic process by means of which sequence diversity of immunoglobulins is generated. 34 0.08 2 23.80 3.25e-03
negative regulation of lymphocyte activation Any process that stops, prevents or reduces the frequency, rate or extent of lymphocyte activation. 34 0.08 2 23.80 3.25e-03
alpha-beta T cell activation The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. 36 0.09 2 22.47 3.64e-03
regulation of transcription Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA. 2702 6.68 15 2.25 3.73e-03
negative regulation of cell adhesion Any process that stops, prevents or reduces the frequency, rate or extent of cell adhesion. 38 0.09 2 21.29 4.05e-03
regulation of B cell activation Any process that modulates the frequency, rate or extent of B cell activation. 38 0.09 2 21.29 4.05e-03
regulation of cytokine production Any process that modulates the frequency, rate, or extent of production of a cytokine. 39 0.10 2 20.75 4.26e-03
immunoglobulin production The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. 39 0.10 2 20.75 4.26e-03
cell-matrix adhesion The binding of a cell to the extracellular matrix via adhesion molecules. 132 0.33 3 9.19 4.46e-03
cell-substrate adhesion The attachment of a cell to the underlying substrate via adhesion molecules. 135 0.33 3 8.99 4.75e-03
regulation of transcription, DNA-dependent Any process that modulates the frequency, rate or extent of DNA-dependent transcription. 2510 6.20 14 2.26 4.77e-03
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids. 2802 6.93 15 2.17 5.16e-03
positive regulation of mononuclear cell proliferation Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation. 43 0.11 2 18.82 5.16e-03
positive regulation of lymphocyte proliferation Any process that activates or increases the rate or extent of lymphocyte proliferation. 43 0.11 2 18.82 5.16e-03
myeloid cell differentiation The process whereby a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages. 142 0.35 3 8.55 5.46e-03
transcription The synthesis of either RNA on a template of DNA or DNA on a template of RNA. 2826 6.99 15 2.15 5.56e-03
negative regulation of multicellular organismal process Any process that stops, prevents or reduces the frequency, rate or extent of an organismal process, the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs. 46 0.11 2 17.59 5.88e-03
transcription, DNA-dependent The synthesis of RNA on a template of DNA. 2588 6.40 14 2.19 6.16e-03
response to stimulus A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. 2860 7.07 15 2.12 6.16e-03
RNA biosynthetic process The chemical reactions and pathways resulting in the formation of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. Includes polymerization of ribonucleotide monomers. 2591 6.40 14 2.19 6.22e-03
cytokine production The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. 153 0.38 3 7.93 6.71e-03
production of molecular mediator of immune response The synthesis or release of any molecular mediator of the immune response following an immunological stimulus, resulting in an increase in its intracellular or extracellular levels. 51 0.13 2 15.86 7.19e-03
RNA metabolic process The chemical reactions and pathways involving RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. 3263 8.07 16 1.98 8.76e-03
cell death The specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. 1152 2.85 8 2.81 8.85e-03
death A permanent cessation of all vital functions: the end of life; can be applied to a whole organism or to a part of an organism. 1152 2.85 8 2.81 8.85e-03
B cell differentiation The process whereby a relatively unspecialized hemopoietic stem cell acquires the specialized features of a B cell. 57 0.14 2 14.19 8.91e-03

Raw data (tab-delimited .txt)